dabigatran has been researched along with Sleep Apnea, Obstructive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perek, N; Puech, C; Roche, F; Zolotoff, C | 1 |
| Aimo, A; De Caterina, R; Petricciuolo, S | 1 |
1 review(s) available for dabigatran and Sleep Apnea, Obstructive
| Article | Year |
|---|---|
[Oral anticoagulation in patients with atrial fibrillation and stage 4 or 5 chronic kidney disease].
Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Diabetes Complications; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Hypertension; Male; Middle Aged; Off-Label Use; Prevalence; Pyrazoles; Pyridines; Pyridones; Renal Insufficiency, Chronic; Risk Factors; Rivaroxaban; Sex Factors; Sleep Apnea, Obstructive; Stroke; Thiazoles; Thromboembolism | 2020 |
1 other study(ies) available for dabigatran and Sleep Apnea, Obstructive
| Article | Year |
|---|---|
Effects of intermittent hypoxia with thrombin in an in vitro model of human brain endothelial cells and their impact on PAR-1/PAR-3 cleavage.
Topics: Blood-Brain Barrier; Brain; Dabigatran; Endothelial Cells; Humans; Hypoxia; Reactive Oxygen Species; Receptor, PAR-1; Sleep Apnea, Obstructive; Thrombin | 2022 |